B4GALNT2

gene product
Cad, GALGT2, Sda
B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]). [supplied by OMIM, Mar 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
70 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
2 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
NovoPro Bioscience Inc.
1 antibody
antibodies-online
20 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Affinity Biosciences
1 antibody
LifeSpan BioSciences, Inc.
21 antibodies
Invitrogen Antibodies
3 antibodies
Biorbyt
5 antibodies
Abnova Corporation
2 antibodies
Aviva Systems Biology
1 antibody
MyBioSource
1 antibody
OriGene
1 antibody
Boster Biological Technology
1 antibody
Creative Diagnostics
2 antibodies
Sigma-Aldrich
1 antibody
St John's Laboratory
1 antibody
Abbexa
3 antibodies
Abgent
1 antibody